Let’s open a thread for this one too. Ascelia is a company from Sweden specializing in cancer diagnostics and treatment.
Company page: Ascelia Pharma - Inderes
Investment research: https://www.inderes.fi/fi/ascelia-pharma-investment-case-24-march-2022-hc-andersen-capital
Like many other companies in the biotech sector, Ascelia has experienced total capitulation in its share price. However, it should be noted that FDA approval is just around the corner, and even though it is a penny stock, that does not in itself dictate the future. Fundamentally, it sounds very interesting if the company can facilitate the detection and treatment of liver metastases.